|
|
| |
 |
Search Results  dr reddy?s |
|
|
| |
| German pain, American gain | 25-MAY-09 |
|
| While headaches on account of Betapharm could ease, Dr Reddy’s is banking on its American operations to boost profitability. |
|
|
|
| Indian pharma cos upbeat on biogenerics | 08-MAY-09 |
|
| Even as the substitutability of biogeneric or biosimilar medicines with their original patented counterparts continues to be a matter of debate world over, Indian drug companies, which have introduced biogeneric products or copies of biotechnology drugs in the country, are bullish over the marketing prospects of “biogenerics" after patents expire in developed markets. Companies such as Dr Reddy’s, Biocon, Reliance Life Sciences and Ranbaxy etc. |
|
|
|
| Re-evaluating pharma | 08-APR-09 |
|
| The travails of the Indian pharmaceutical major Wockhardt, which is having to consider the sale of its non-core businesses and to perhaps bring in a strategic partner so as to meet its debt obligations, highlight the none too happy turn that the global ambitions of Indian pharma companies have taken. |
|
|
|
|
|
|
| Pharma cos eye small buys to stay fit | 24-DEC-08 |
|
| Dr Reddy’s Laboratories, Nicholas Piramal and other Indian drug makers are relying on niche and smaller value, acquisition strategy for growth owing to global slowdown and failure of big-ticket |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
 |
Most Popular |
|
|
|
|
|
|
|
|
|
|
|
| |
 |
Hot Searches |
|
|
|
|
|
|
|
|
|
|
|
|
Content Guide
